Global and India Bacillus Coagulans Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Bacillus Coagulans Market Report & Forecast 2024-2034
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Market Analysis and InsightsGlobal and India Bacillus Coagulans Market
This report focuses on global and India Bacillus Coagulans market, also covers the segmentation data of other regions in regional level and county level.
The global Bacillus Coagulans revenue was US$ 150.5 million in 2024 and is forecast to a readjusted size of US$ 278.7 million by 2034 with a CAGR of 9.1% during the forecast period (2024-2034).
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 57%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
Global Bacillus Coagulans Scope and Market Size
Bacillus Coagulans market is segmented in regional and country, by players, by cellular activity and by application. Companies, stakeholders, and other participants in the global Bacillus Coagulans market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by cellular activity and by application for the period 2018-2034.
For India market, this report focuses on the Bacillus Coagulans market size by players, by Cellular Activity and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Segment by Cellular Activity
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Food and Beverage
Drugs
Supplement Products
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Bacillus Coagulans definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by cellular activity, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Bacillus Coagulans companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Bacillus Coagulans in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by cellular activity, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by cellular activity, by application and by region, sales, and revenue for each segment.
Chapter 8China by cellular activity, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by cellular activity, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacillus Coagulans sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Market Analysis and InsightsGlobal and India Bacillus Coagulans Market
This report focuses on global and India Bacillus Coagulans market, also covers the segmentation data of other regions in regional level and county level.
The global Bacillus Coagulans revenue was US$ 150.5 million in 2024 and is forecast to a readjusted size of US$ 278.7 million by 2034 with a CAGR of 9.1% during the forecast period (2024-2034).
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 57%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
Global Bacillus Coagulans Scope and Market Size
Bacillus Coagulans market is segmented in regional and country, by players, by cellular activity and by application. Companies, stakeholders, and other participants in the global Bacillus Coagulans market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by cellular activity and by application for the period 2018-2034.
For India market, this report focuses on the Bacillus Coagulans market size by players, by Cellular Activity and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.
By Company
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Segment by Cellular Activity
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Segment by Application
Food and Beverage
Drugs
Supplement Products
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Bacillus Coagulans definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by cellular activity, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Bacillus Coagulans companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Bacillus Coagulans in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by cellular activity, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by cellular activity, by application and by region, sales, and revenue for each segment.
Chapter 8China by cellular activity, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by cellular activity, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacillus Coagulans sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices